The simulation of strongly interacting many-body systems is a key objective of quantum physics research, as it can help to ...
They say irony is dead. But in the market for graphics processing units—a market worth around $65 billion today, expected to approach $300 billion by 2029, integral to nearly all industries, and ...
For decades, quantum computing has felt like something out of science fiction — abstract, theoretical, and always “10 years ...
Hamas was reviewing Donald Trump's plan for Gaza on Tuesday, while Prime Minister Benjamin Netanyahu said the Israeli military would stay in most of the territory after he gave the US president his ...
Abstract: The existing shared control schemes and automatic control schemes are almost designed separately. Based on the designed constrained function and shared-constrained function, this paper ...
Founders are often the first investors in their companies. And whether that business gains venture backing, raises money from friends and family, or remains self-funded, it can make determining your ...
Insurance companies continue to innovate. On Oct. 1, Cigna will roll out a policy that tracks how physicians bill. It will flag those who submit a higher proportion of level four or level five visits ...
This content has been selected, created and edited by the Finextra editorial team based upon its relevance and interest to our community. Swift will work with Consensys on a conceptual prototype of ...
A trans-Atlantic journey, three robots and some trade secrets all went into the reviving of the childhood favorite. A trans-Atlantic journey, three robots and some ...
There's no doubt that Microsoft's multibillion-dollar partnership with OpenAI has been under immense strain and tension, especially with the latter's plan to evolve into a for-profit venture to avoid ...
Keurig Dr Pepper’s (NASDAQ:KDP) decision to split its beverage and coffee business will prove to be the right move, Barclays says, but the complex mechanics of the separation presents “elevated noise ...
How Health Systems, Pharmacy Teams Tackle Rare Disease Therapy Barriers: David Mitchell, PharmD, MBA
David Mitchell, PharmD, MBA, senior pharmacist manager and assistant clinical professor at UC Davis, addresses how health systems are overcoming financial, operational, and access challenges for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results